BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/30/2022 10:14:41 PM | Browse: 135 | Download: 161
Publication Name World Journal of Clinical Cases
Manuscript ID 76429
Country China
Category Mathematical & Computational Biology
Manuscript Type Clinical and Translational Research
Article Title Network pharmacology and molecular docking reveal zedoary turmeric-trisomes in Inflammatory bowel disease with intestinal fibrosis
Manuscript Source Unsolicited Manuscript
All Author List Lie Zheng, Yong-Yi Ji, Yan-Cheng Dai, Xin-Li Wen and Shi-Cheng Wu
Funding Agency and Grant Number
Funding Agency Grant Number
General Research of Xi’an Science and Technology Planning Project 2022JH-YBYJ-0265
Shaanxi Province Natural Science Basic Research Program-General Project 2019JM-580
Shaanxi Province Natural Science Basic Research Program-General Project 2021SF-314
Project of Shaanxi Administration of Traditional Chinese Medicine 2019-ZZ-JC010
Shaanxi Provincial Hospital of Traditional Chinese Medicine 2021-07
Shaanxi Provincial Hospital of Traditional Chinese Medicine 2018-04
Corresponding Author Shi-Cheng Wu, N/A, N/A, Department of Proctology, Gansu Academy of Traditional Chinese Medicine, GanSu Hospital of Traditional Chinese Medicine, No. 418 Guazhou Road, Qilihe District, Lanzhou Gansu Province, Gansu Province, China. 594068860@qq.com
Key Words Network pharmacology; Molecular docking; Zedoary turmeric trisomes; Inflammatory bowel disease; Intestinal fibrosis
Core Tip Intestinal fibrosis is one of the common complications of inflammatory bowel disease (IBD). Finding effective drug treatment is an important issue that needs to be solved at the moment. The mechanism of zedoary turmeric-trisomes in the treatment of IBD with intestinal fibrosis can be predicted through network pharmacology and molecular docking, so as to provide theoretical reference for it to better play its therapeutic role.
Citation Zheng L, Ji YY, Dai YC, Wen XL, Wu SC. Network pharmacology and molecular docking reveal zedoary turmeric-trisomes in Inflammatory bowel disease with intestinal fibrosis. World J Clin Cases 2022; 10(22): 7674-7685
Received
2022-03-16 10:39
Peer-Review Started
2022-03-16 10:42
To Make the First Decision
Return for Revision
2022-04-12 11:25
Revised
2022-05-05 07:59
Second Decision
2022-06-29 03:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-06-30 22:14
Articles in Press
2022-06-30 22:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-07-11 01:53
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com